MedPath

Cromolyn Sodium

Cromolyn Sodium Inhalation Solution, USP For Oral Inhalation Use Only- Not for Injection Rx only

Approved
Approval ID

aebec664-ed80-447c-9789-0cf47c8b7429

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 4, 2022

Manufacturers
FDA

Micro Labs Limited

DUNS: 862174955

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cromolyn Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42571-350
Application NumberANDA213658
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cromolyn Sodium
Product Specifications
Route of AdministrationINTRABRONCHIAL
Effective DateMay 4, 2022
FDA Product Classification

INGREDIENTS (2)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
CROMOLYN SODIUMActive
Quantity: 20 mg in 2 mL
Code: Q2WXR1I0PK
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cromolyn Sodium - FDA Drug Approval Details